(Q39447453)

12 September 2017

1 reference

title

Sumatriptan. An updated review of its use in migraine (English)

1 reference

12 September 2017

1 reference

2

A Markham

0 references

author name string

C M Perry

series ordinal

1

1 reference

12 September 2017

A Markham

series ordinal

2

1 reference

12 September 2017

publication date

1 June 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

55

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

889-922

1 reference

Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice

12 September 2017

cites work

1 reference

12 December 2020

Improvements in health-related quality of life with sumatriptan treatment for migraine.

1 reference

12 December 2020

Quality of life assessment among migraine patients treated with sumatriptan

1 reference

12 December 2020

A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice

1 reference

12 December 2020

Burden of migraine. A review of its socioeconomic impact

1 reference

12 December 2020

The impact of drug therapy on quality of life in headache and migraine

1 reference

12 December 2020

Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan

1 reference

12 December 2020

A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine

1 reference

12 December 2020

Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System

1 reference

12 December 2020

Clinical presentation and treatment of migraine

1 reference

12 December 2020

Side effects of ergotamine

1 reference

12 December 2020

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

1 reference

12 December 2020

Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes

1 reference

12 December 2020

Distribution and excretion of sumatriptan in human milk

1 reference

12 December 2020

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients

1 reference

12 December 2020

Is chest pain after sumatriptan oesophageal in origin?

1 reference

12 December 2020

Sumatriptan: vasoactive effect on human dural vessels, demonstrated by subselective angiography

1 reference

12 December 2020

Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.

1 reference

12 December 2020

Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.

1 reference

12 December 2020

Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?

1 reference

12 December 2020

Sumatriptan (Imitrex) transport by the human placenta

1 reference

12 December 2020

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

1 reference

12 December 2020

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

1 reference

12 December 2020

Characteristics and determinants of sumatriptan-associated chest pain

1 reference

12 December 2020

Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions

1 reference

12 December 2020

Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients

1 reference

12 December 2020

Transmural myocardial infarction with sumatriptan

1 reference

12 December 2020

Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity

1 reference

12 December 2020

Migraine in the United States: a review of epidemiology and health care use.

1 reference

12 December 2020

Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study

1 reference

12 December 2020

1 reference

12 December 2020

The Clinical Pharmacology, Pharmacokinetics and Metabolism of Sumatriptan

1 reference

12 December 2020

Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane

1 reference

12 December 2020

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

1 reference

12 December 2020

Long-term subcutaneous sumatriptan in cluster headache

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.

1 reference

12 December 2020

1 reference

12 December 2020

Cerebral blood flow during migraine attacks without aura and effect of sumatriptan

1 reference

12 December 2020

The safety and tolerability of sumatriptan: an overview

1 reference

12 December 2020

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

1 reference

12 December 2020

Migraine patients experience poorer subjective well-being/quality of life even between attacks.

1 reference

12 December 2020

Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy

1 reference

12 December 2020

Healthcare resource and lost labour costs of migraine headache in the US.

1 reference

12 December 2020

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

1 reference

12 December 2020

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

1 reference

12 December 2020

Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks

1 reference

12 December 2020

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

1 reference

12 December 2020

[3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors

1 reference

12 December 2020

A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro

1 reference

12 December 2020

Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences

1 reference

12 December 2020

Single dose pharmacokinetics of sumatriptan in healthy volunteers

1 reference

12 December 2020

Activation of sensory nerves in guinea-pig isolated basilar artery by nicotine: evidence for inhibition of trigeminal sensory neurotransmission by sumatriptan

1 reference

12 December 2020

A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group

1 reference

12 December 2020

Disposition of sumatriptan in laboratory animals and humans

1 reference

12 December 2020

Paroxetine treatment and the prolactin response to sumatriptan

1 reference

12 December 2020

Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group

1 reference

12 December 2020

Intranasal medications for the treatment of migraine and cluster headache

1 reference

12 December 2020

[Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results]

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings

1 reference

12 December 2020

Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine

1 reference

12 December 2020

Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients

1 reference

12 December 2020

Oral sumatriptan-associated transmural myocardial infarction

1 reference

12 December 2020

Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis

1 reference

12 December 2020

Is overuse of sumatriptan a problem?

1 reference

12 December 2020

Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data

1 reference

12 December 2020

Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate

1 reference

12 December 2020

Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain

1 reference

12 December 2020

Pattern of sumatriptan use and overuse in general practice.

1 reference

12 December 2020

Sumatriptan absorption from different regions of the human gastrointestinal tract

1 reference

12 December 2020

Assessment of Peripheral Vascular Effects of Antimigraine Drugs in Humans

1 reference

12 December 2020

Diagnosis and management of migraine

1 reference

12 December 2020

Unstable angina pectoris associated with Imitrex therapy

1 reference

12 December 2020

Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers

1 reference

12 December 2020

5-Hydroxytryptamine and the pathophysiology of migraine

1 reference

12 December 2020

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

1 reference

12 December 2020

The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group

1 reference

12 December 2020

Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study

1 reference

12 December 2020

Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group

1 reference

12 December 2020

5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519

1 reference

12 December 2020

The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.

1 reference

12 December 2020

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

1 reference

12 December 2020

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

1 reference

12 December 2020

Lack of an interaction between propranolol and sumatriptan

1 reference

12 December 2020

Subcutaneous sumatriptan during the migraine aura

1 reference

12 December 2020

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine

1 reference

12 December 2020

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

1 reference

12 December 2020

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

1 reference

12 December 2020

1 reference

12 December 2020

Sumatriptan and daily headache

1 reference

12 December 2020

Treatment of juvenile migraine with subcutaneous sumatriptan.

1 reference

12 December 2020

Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).

1 reference

12 December 2020

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

1 reference

12 December 2020

Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients

1 reference

12 December 2020

Coronary vasospasm secondary to subcutaneous administration of sumatriptan

1 reference

12 December 2020

Increasing the options for effective migraine management

1 reference

12 December 2020

Sumatriptan. A pharmacoeconomic review of its use in migraine

1 reference

12 December 2020

Postmarketing study of cardiovascular adverse reactions associated with sumatriptan

1 reference

12 December 2020

Misuse of sumatriptan

1 reference

12 December 2020

The clinical profile of sumatriptan: safety and tolerability

1 reference

12 December 2020

Improved description of the migraine aura by a diagnostic aura diary

1 reference

12 December 2020

Sumatriptan and ischaemic heart disease

1 reference

12 December 2020

The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors

1 reference

12 December 2020

Sumatriptan and cerebral perfusion in healthy volunteers

1 reference

12 December 2020

Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences

1 reference

12 December 2020

Sumatriptan clinical pharmacokinetics

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.

1 reference

12 December 2020

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

1 reference

12 December 2020

Vasospasm-induced myocardial infarction with sumatriptan

1 reference

12 December 2020

Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers

1 reference

12 December 2020

Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation.

1 reference

12 December 2020

Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths

1 reference

12 December 2020

Coronary angiography in migraine patient after subcutaneous sumatriptan

1 reference

12 December 2020

Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Burden of migraine: societal costs and therapeutic opportunities

1 reference

12 December 2020

Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble

1 reference

12 December 2020

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group

1 reference

12 December 2020

The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache

1 reference

12 December 2020

Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat.

1 reference

12 December 2020

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

1 reference

12 December 2020

Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses

1 reference

12 December 2020

Oral sumatriptan in the treatment of recurrent headache

1 reference

12 December 2020

Cardiac arrest following use of sumatriptan

1 reference

12 December 2020

Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache

1 reference

12 December 2020

The mode of action of sumatriptan is vascular? A debate

1 reference

12 December 2020

Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.

1 reference

12 December 2020

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

12 December 2020

10.2165/00003495-199855060-00020

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1044691563

0 references

1 reference